跳至主要内容
临床试验/ACTRN12614000674639
ACTRN12614000674639招募中未知

Terminal ProB-Type Natriuretic Peptide and Late Pulmonary Hypertension Secondary to Chronic Lung Disease in Premature Infants Born at Less Than 30 Weeks Gestation

niversity of Otago0 个研究点目标入组 50 人开始时间: 2014年6月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
1 Days 至 3 Days(—)
性别
All

入选标准

  • Infants born at < 30 weeks gestation and cared for at Christchurch Women's Hospital NICU.

排除标准

  • Known structural airway or lung anomalies, congenital anomalies of the pulmonary arteries or pulmonary veins, major systemic to pulmonary artery collateral vessels, congenital heart disease(except those with patent ductus arteriosus, patent foramen oval or atrial septal defect), severe liver disease and persistent pulmonary hypertension of the newborn (from birth).

研究者

相似试验